Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
4,287 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02349594 | Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease | completed | Phase 4 | 6 | Radboud University Medical CenterOTHER | 1 | Nov 10, 2015 | clinicaltrials |
| NCT01577212 | Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy(IDEAL-VMAT) | terminated | Phase 2 | 6 | Radboud University Medical CenterOTHER | 1 | Nov 9, 2015 |
| clinicaltrials |
| NCT01832051 | Clinical Value of 89Zr-trastuzumab PET | completed | Phase 2 | 20 | University Medical Center GroningenOTHER | 1 | Nov 5, 2015 | clinicaltrials |
| NCT00879333 | Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)(GRANITE-1) | completed | Phase 3 | 656 | Novartis PharmaceuticalsINDUSTRY | 22 | Nov 3, 2015 | clinicaltrials |
| NCT01731379 | Optical Detection of Peripheral Nerve Bundles During Surgery(NerveSpect) | completed | — | 35 | Philips HealthcareINDUSTRY | 1 | Nov 3, 2015 | clinicaltrials |
| NCT02083848 | Detection of Loco-regional Invasion of Cervical Cancer With 7 Tesla MRI(DETECT) | completed | N/A | 23 | UMC UtrechtOTHER | 1 | Nov 3, 2015 | clinicaltrials |
| NCT01227213 | The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma | completed | — | 20 | Radboud University Medical CenterOTHER | 1 | Oct 30, 2015 | clinicaltrials |
| NCT00511459 | Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients | completed | Phase 2 | 228 | AmgenINDUSTRY | 13 | Oct 29, 2015 | clinicaltrials |
| NCT00372996 | Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer | terminated | Phase 2 | 219 | PfizerINDUSTRY | 9 | Oct 28, 2015 | clinicaltrials |
| NCT00548704 | A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines | completed | Phase 2 / Phase 3 | 57 | Valerio TherapeuticsINDUSTRY | 5 | Oct 21, 2015 | clinicaltrials |
| NCT01234311 | A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer | completed | Phase 3 | 1,245 | Active Biotech ABINDUSTRY | 37 | Oct 21, 2015 | clinicaltrials |
| NCT00085163 | Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon | completed | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Oct 20, 2015 | clinicaltrials |
| NCT00103506 | Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma | completed | Phase 3 | 646 | Janssen Research & Development, LLCINDUSTRY | 17 | Oct 19, 2015 | clinicaltrials |
| NCT01290809 | Prophylactic Cranial Irradiation (PCI) Cognitive Tests in Non-small Cell Lung Cancer (NSCLC) Patients | completed | — | 170 | Maastricht Radiation OncologyOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00546247 | A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1) | terminated | Phase 1 / Phase 2 | 26 | Bristol-Myers SquibbINDUSTRY | 2 | Oct 12, 2015 | clinicaltrials |
| NCT00633789 | Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types | completed | Phase 2 | 597 | Bristol-Myers SquibbINDUSTRY | 9 | Oct 9, 2015 | clinicaltrials |
| NCT01985295 | Combined Modality Treatment of Sarcomas of the Extremities(PASART-1) | completed | Phase 1 | 12 | The Netherlands Cancer InstituteOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT00377559 | Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer(MYOTAX) | completed | Phase 2 | 70 | Catharina Ziekenhuis EindhovenOTHER | 1 | Oct 6, 2015 | clinicaltrials |
| NCT02130011 | Dose-Guided Radiotherapy in Oesophageal Cancer: Managing the Real Dose(DGRT) | completed | N/A | 20 | Maastricht Radiation OncologyOTHER | 1 | Oct 6, 2015 | clinicaltrials |
| NCT02188290 | Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation | completed | — | 178 | Kiadis PharmaINDUSTRY | 6 | Oct 6, 2015 | clinicaltrials |
| NCT01090011 | Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer | completed | Phase 1 | 171 | Boehringer IngelheimINDUSTRY | 2 | Oct 2, 2015 | clinicaltrials |
| NCT01946490 | Time Trends in Waiting Times of NSCLC Patients. | withdrawn | — | 0 | Maastricht Radiation OncologyOTHER | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00791778 | Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer | completed | Phase 2 | 246 | BayerINDUSTRY | 14 | Sep 28, 2015 | clinicaltrials |
| NCT02243059 | Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer(MILO) | withdrawn | Phase 4 | 0 | Maastricht University Medical CenterOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT00317408 | Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma | unknown | N/A | 96 | European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin LymphomaOTHER | 12 | Sep 25, 2015 | clinicaltrials |
| NCT00377780 | Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer(MYOHERTAX) | terminated | Phase 2 | 60 | Laurence J.C. van WarmerdamOTHER | 1 | Sep 23, 2015 | clinicaltrials |
| NCT02480010 | A Study of Pertuzumab in Participants With Prostate Cancer | terminated | Phase 2 | 68 | Hoffmann-La RocheINDUSTRY | 6 | Sep 18, 2015 | clinicaltrials |
| NCT00215631 | Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer? | terminated | Phase 3 | 100 | Erasmus Medical CenterOTHER | 1 | Sep 15, 2015 | clinicaltrials |
| NCT01494883 | Mindfulness for Lung Cancer Patients and Partners | completed | N/A | 107 | Radboud University Medical CenterOTHER | 1 | Sep 11, 2015 | clinicaltrials |
| NCT02205853 | Implementation of Physical Cancer Rehabilitation Programmes in a European Healthcare System. | unknown | N/A | 10 | Radboud University Medical CenterOTHER | 1 | Sep 7, 2015 | clinicaltrials |
| NCT00528567 | BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer | completed | Phase 3 | 2,591 | Hoffmann-La RocheINDUSTRY | 40 | Sep 4, 2015 | clinicaltrials |
| NCT00259922 | Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | completed | Phase 3 | 485 | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 12 | Sep 2, 2015 | clinicaltrials |
| NCT00817518 | A Dose-Escalating Study of RO4987655 in Patients With Advanced Solid Tumors | completed | Phase 1 | 145 | Hoffmann-La RocheINDUSTRY | 5 | Sep 2, 2015 | clinicaltrials |
| NCT02538380 | EUS-B-FNA vs EUS-FNA for Left Adrenal Gland Analysis in Lung Cancer Patients | unknown | N/A | 40 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT01612325 | Radioactive Holmium Microspheres for the Treatment of Unresectable Liver Metastases(HEPAR-2) | completed | Phase 2 | 56 | UMC UtrechtOTHER | 1 | Aug 27, 2015 | clinicaltrials |
| NCT02491892 | A Study of Pertuzumab in Participants With Metastatic Breast Cancer | completed | Phase 2 | 79 | Hoffmann-La RocheINDUSTRY | 8 | Aug 25, 2015 | clinicaltrials |
| NCT01183858 | A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS) | completed | Phase 3 | 315 | Hoffmann-La RocheINDUSTRY | 9 | Aug 19, 2015 | clinicaltrials |
| NCT01215526 | A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer(FAST-NL) | completed | — | 274 | Ferring PharmaceuticalsINDUSTRY | 1 | Aug 19, 2015 | clinicaltrials |
| NCT01621425 | Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity(LEANDOC) | completed | — | 25 | Radboud University Medical CenterOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02002312 | Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer | completed | Phase 2 | 14 | Radboud University Medical CenterOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01014208 | Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma(ORCHARRD) | completed | Phase 3 | 447 | GlaxoSmithKlineINDUSTRY | 26 | Aug 7, 2015 | clinicaltrials |
| NCT00003636 | Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer | completed | Phase 3 | 704 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 15 | Aug 5, 2015 | clinicaltrials |
| NCT02303938 | Effects of Exercise on Cognitive Function in Glioma Patients | completed | N/A | 60 | Tilburg UniversityOTHER | 1 | Aug 4, 2015 | clinicaltrials |
| NCT00700102 | A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer. | completed | Phase 3 | 820 | Hoffmann-La RocheINDUSTRY | 15 | Jul 30, 2015 | clinicaltrials |
| NCT01096654 | SPARTACUS: Subtyping Primary Aldosteronism: a Randomized Trial Comparing Adrenal Vein Sampling and Computed Tomography Scan.(SPARTACUS) | completed | Phase 3 | 200 | Radboud University Medical CenterOTHER | 1 | Jul 16, 2015 | clinicaltrials |
| NCT01317589 | Treatment of Pain in Head-and-Neck Cancer Patients: is Methadone More Effective?(310111-4) | completed | Phase 4 | 134 | Maastricht University Medical CenterOTHER | 1 | Jul 16, 2015 | clinicaltrials |
| NCT01478594 | A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy | completed | Phase 2 | 265 | AVEO Pharmaceuticals, Inc.INDUSTRY | 12 | Jul 8, 2015 | clinicaltrials |
| NCT02368990 | T790M Mutation Positive 2nd Line STandard of cAre Registry(T-STAR) | withdrawn | — | 0 | AstraZenecaINDUSTRY | 9 | Jul 8, 2015 | clinicaltrials |
| NCT00510068 | Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors(RADIANT-3) | completed | Phase 3 | 410 | Novartis PharmaceuticalsINDUSTRY | 18 | Jul 1, 2015 | clinicaltrials |
| NCT01423500 | ALL-SCT BFM International- HSCT in Children and Adolescents With ALL(ALL-SCT-BFMi) | unknown | Phase 3 | 405 | St. Anna KinderkrebsforschungOTHER | 11 | Jun 26, 2015 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials